CLSI FR02 | Isavuconazole Breakpoints for Aspergillus fumigatus, 1st Edition
This CLSI rationale document is based on the need for guidance on the interpretation of antifungal agents for invasive aspergillosis.
Microbiology | Standards
CLSI has a longstanding globally trusted reputation for its diligent development of Microbiology and Antimicrobial Susceptibility Testing (AST) standards and guidelines on test methods and QC procedures. Additionally, CLSI annually creates and revises AST breakpoints to meet global public health challenges related to antimicrobial resistance. CLSI’s library of Microbiology standards and AST guidelines establish vital performance criteria and best practice guidelines for use in the clinical microbiology laboratory field.
Featured Products
CLSI MR16 | Aminoglycoside Breakpoints for Enterobacterales and Pseudomonas aeruginosa, 1st Edition
This CLSI rationale document is based on CLSI agenda items submitted by the CLSI Aminoglycoside Ad Hoc Working Group.
CLSI M100 | Performance Standards for Antimicrobial Susceptibility Testing, 35th Edition
CLSI M100-Ed35 includes updated tables for the Clinical and Laboratory Standards Institute antimicrobial susceptibility testing standards CLSI M02| Performance Standards for Antimicrobial Disk Susceptibility Tests, 14th Edition (2024), CLSI M07| Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 12th Edition (2024), and CLSI M11 | Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 9th Edition (2018).
CLSI M64 | Implementation of Taxonomy Nomenclature Changes, 1st Edition
CLSI M64 includes recommendations for implementing nomenclature changes for medically important bacteria and fungi that are identified and reported from clinical specimens, especially when testing for antimicrobial susceptibility.